
If you are looking for new additions to your portfolio, then it could be worth listening to what analysts are saying about the popular ASX shares named below, courtesy of The Bull.Â
Here’s what they are recommending this week:
Dicker Data Ltd (ASX: DDR)
The team at Vestra Capital is positive on this software and hardware distributor and has named it as a buy this week.
Vestra highlights Dicker Data’s strong top line growth, attractive dividend yield, and exposure to artificial intelligence (AI) spending as reasons to buy. It said:
This technology company distributes hardware and software solutions. It benefits from enterprise spending on AI capable servers, network upgrades and end point security hardware. It generated gross revenue of $2.1 billion in the first half of 2026, up 14.2 per cent on the prior corresponding period. Net profit after tax of $60.7 million was up 54.1 per cent.
Management has upgraded full year gross revenue guidance to between $4.3 billion and $4.4 billion, alongside profit before tax guidance of between $162 million and $165 million. Double digit top line momentum, an appealing dividend yield and increasing exposure to AI infrastructure spending provides a bright outlook, in my view.
Pro Medicus Ltd (ASX: PME)
Over at Medallion Financial Group, it has named this medical imaging software provider as an ASX share to buy.
Medallion believes that recent share price weakness has created a buying opportunity for investors. It explains:
Pro Medicus is a global leader in medical imaging software, with its Visage platform increasingly adopted by major US hospital networks. Revenue of $261.7 million in full year 2026 rose 22.9 per cent on the prior corresponding period. Underlying net profit after tax of $144.7 million was up 24.1 per cent. Revenue and underlying net profit exceeded expectations, while the underlying earnings before interest and tax margin reached an exceptional 74.9 per cent.
It signed 10 new contacts worth $407 million in full year 2026. It renewed six contracts on five year terms to the value of $141 million. Recent share price weakness provides an attractive entry point into a high quality growth businesses.
Seek Ltd (ASX: SEK)
Gray Perry Wealth Advisers is a fan of job listings giant Seek and is tipping it as an ASX share to buy this week.
The wealth adviser highlights Seek’s improving return on equity and healthy dividend as reasons to be positive. It said:
Seek operates a leading online employment marketplace, with a dominant position in Australia and established operations across Asia. Its scalable model, strong margins and international expansion provide attractive long-term growth potential. Despite softer job-ad volumes, fiscal year 2026 net revenue rose 10 per cent and EBITDA increased 15 per cent, demonstrating pricing power and operational resilience.Â
We’re forecasting earnings to grow about 9.5 per cent annually in the next two years. An improving return on equity and a healthy dividend further support the investment case.
The post Experts name 3 top ASX shares to buy this week appeared first on The Motley Fool Australia.
Should you invest $1,000 in Dicker Data right now?
Before you buy Dicker Data shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Dicker Data wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 August 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Buy, hold, sell: Pro Medicus, BHP, CBA shares
- These ASX 50 shares have lost up to 60%. Is the sell-off overdone?
- 5 things to watch on the ASX 200 on Monday
- Top 3 ASX healthcare shares to buy after a brutal year
- 40 ASX shares with ex-dividend dates next week
Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Dicker Data. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.